UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

The lancet oncology, 2010-10, Vol.11 (10), p.962-972

2010

Volltextzugriff (PDF)

The role of bail and pretrial detention in the reproduction of racial inequalities

Sociology compass, 2018-05, Vol.12 (5), p.n/a

Menefee, Michael R.

2018

Volltextzugriff (PDF)

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial

Journal of clinical oncology, 2017-10, Vol.35 (29), p.3315-3321

2017

Volltextzugriff (PDF)

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2012-09, Vol.97 (9), p.3179-3184

2012

Volltextzugriff (PDF)

The Effect of Split Sentences on Employment and Future Criminal Justice Involvement: Evidence from a Natural Experiment

Social forces, 2022-12, Vol.101 (2), p.829-863

2022

Volltextzugriff (PDF)

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

Clinical cancer research, 2018-02, Vol.24 (4), p.744-752

2018

Volltextzugriff (PDF)

Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy

The journal of clinical endocrinology and metabolism, 2020-07, Vol.105 (7), p.e2346-e2357

2020

Volltextzugriff (PDF)

A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H

The journal of clinical endocrinology and metabolism, 2014-05, Vol.99 (5), p.1687-1693

2014

Volltextzugriff (PDF)

Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers

Molecular cancer therapeutics, 2012-10, Vol.11 (10), p.2105-2115

2012

Volltextzugriff (PDF)

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

Investigational new drugs, 2019-08, Vol.37 (4), p.755-762

2019

Volltextzugriff (PDF)

Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib

Journal of clinical oncology, 2010-07, Vol.28 (19), p.e312-e313

2010

Volltextzugriff (PDF)

Impact of Motivating Language on Team Creative Performance

The Journal of computer information systems, 2009-09, Vol.50 (1), p.133-140

2009

Volltextzugriff (PDF)

Present and future suitable habitat for the black-tailed prairie dog ecosystem

Biological conservation, 2023-10, Vol.286, p.110241, Article 110241

2023

Volltextzugriff (PDF)

Rural sourcing in North Carolina: promoting economic sustainability

International journal of sustainable strategic management, 2014, Vol.4 (3), p.210

2014

Volltextzugriff (PDF)

Competitive intelligence: evidence from Turkish SMEs

International journal of entrepreneurship and small business, 2011, Vol.13 (3), p.333

2011

Volltextzugriff (PDF)

Organizational life cycle and performance among SMEs: Generic strategies for high and low performers

International journal of commerce and management, 2008-11, Vol.18 (4), p.313-330

2008

Volltextzugriff (PDF)

Mixed response to immunotherapy in lung cancer

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.122-122

2019

Volltextzugriff (PDF)

Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma

American journal of cancer research, 2013-01, Vol.3 (4), p.390-401

2013

Volltextzugriff (PDF)

Strategy as a response to organizational uncertainty: an alternative perspective on the strategy-performance relationship

Management decision, 2000-10, Vol.38 (8), p.520-530

2000

Volltextzugriff (PDF)

Project Switch: Docetaxel as a potential synthetic control in metastatic non-small cell lung cancer (mNSCLC) trials

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9105-9105

2019

Volltextzugriff (PDF)

Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors

Clinical cancer research, 2014-09, Vol.20 (18), p.4747-4757

2014

Volltextzugriff (PDF)

Systemic therapeutic approaches to advanced thyroid cancers

American Society of Clinical Oncology educational book, 2012-06 (32), p.389-392

2012

Volltextzugriff (PDF)

P3.02c-086 Genomic Heterogeneity in Tumors Demonstrating a Mixed Response to Nivolumab for Stage IV Squamous Cell Carcinoma of the Lung: Topic: IT Biomarkers

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1330-S1331

2017

Volltextzugriff (PDF)

P3.02c-086 Genomic Heterogeneity in Tumors Demonstrating a Mixed Response to Nivolumab for Stage IV Squamous Cell Carcinoma of the Lung

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1330-S1331

2017

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Englisch
(136)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(63)
Humans
(54)
Female
(50)
Middle Aged
(37)
Aged
(29)
Biological And Medical Sciences
(23)
Adult
(22)
Medical Sciences
(22)
Treatment Outcome
(22)
Male
(17)
Oncology
(14)
Urinary Incontinence, Stress - Surgery
(14)
Urology & Nephrology
(13)
Urinary Incontinence
(12)
Obstetrics & Gynecology
(11)
Aged, 80 And Over
(10)
Nephrology. Urinary Tract Diseases
(9)
Urinary Incontinence, Stress - Physiopathology
(9)
Urology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

The role of bail and pretrial detention in the reproduction of racial inequalities

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

The Effect of Split Sentences on Employment and Future Criminal Justice Involvement: Evidence from a Natural Experiment

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy

A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H

Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib

Impact of Motivating Language on Team Creative Performance

Present and future suitable habitat for the black-tailed prairie dog ecosystem

Rural sourcing in North Carolina: promoting economic sustainability

Competitive intelligence: evidence from Turkish SMEs

Organizational life cycle and performance among SMEs: Generic strategies for high and low performers

Mixed response to immunotherapy in lung cancer

Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma

Strategy as a response to organizational uncertainty: an alternative perspective on the strategy-performance relationship

Project Switch: Docetaxel as a potential synthetic control in metastatic non-small cell lung cancer (mNSCLC) trials

Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors

Systemic therapeutic approaches to advanced thyroid cancers

P3.02c-086 Genomic Heterogeneity in Tumors Demonstrating a Mixed Response to Nivolumab for Stage IV Squamous Cell Carcinoma of the Lung: Topic: IT Biomarkers

P3.02c-086 Genomic Heterogeneity in Tumors Demonstrating a Mixed Response to Nivolumab for Stage IV Squamous Cell Carcinoma of the Lung

Suchergebnisse filtern